VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
First! Merck's Subcutaneous PD-1 Combo Nominated for Breakthrough Therapy Designation
First! Merck's Subcutaneous PD-1 Combo Nominated for Breakthrough Therapy Designation
May 21, 2026 15:39 CST Updated 17:14
Share:
